Literature DB >> 6850416

The in vitro inhibition of hepatic ferrochelatase by divalent lead and other soft metal ions.

R R Gaertner, B R Hollebone.   

Abstract

A solubilized protein with ferrochelatase activity has been extracted from hepatic mitochondria of Sprague-Dawley rats. Under anerobic conditions in the presence of sodium ascorbate the ferrochelatase velocity was typically 1.8 nM X min-1 X mg-1. The extract also displayed zinc chelatase activity of 1.2 nM X min-1 X mg-1 without either anerobic conditions or ascorbate. In both cases substrate inhibition occurred for metal ion and deuteroporphyrin, but in the linear range a noncompetitive two-site mechanism was observed. The ferrochelatase activity is inhibited by divalent copper, mercury, and lead ions and the sodium salt of p-chloromercuribenzoate and is replaced by zinc chelation activity. This evidence suggests that the metal-binding site includes a thiol group. The inhibition of the site is greatest with Cu2+ and decreases with increasing ionic radius to Pb2+. This observation implies that the binding site is stereochemically adapted to the small Fe2+ ion and to some extent protected from larger, sulfur-binding ions which can inhibit ferrochelatase activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6850416     DOI: 10.1139/o83-030

Source DB:  PubMed          Journal:  Can J Biochem Cell Biol        ISSN: 0714-7511


  3 in total

1.  Effects of lead oxide and iron on glucose fermentation by Clostridium sp.

Authors:  A J Francis; C J Dodge
Journal:  Arch Environ Contam Toxicol       Date:  1987-07       Impact factor: 2.804

2.  Identification and characterization of solvent-filled channels in human ferrochelatase.

Authors:  Amy E Medlock; Wided Najahi-Missaoui; Teresa A Ross; Tamara A Dailey; Joseph Burch; Jessica R O'Brien; William N Lanzilotta; Harry A Dailey
Journal:  Biochemistry       Date:  2012-06-28       Impact factor: 3.162

3.  Product release rather than chelation determines metal specificity for ferrochelatase.

Authors:  Amy E Medlock; Michael Carter; Tamara A Dailey; Harry A Dailey; William N Lanzilotta
Journal:  J Mol Biol       Date:  2009-08-22       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.